T
Thomas H. Brannagan
Researcher at Columbia University
Publications - 76
Citations - 3716
Thomas H. Brannagan is an academic researcher from Columbia University. The author has contributed to research in topics: Peripheral neuropathy & Amyloidosis. The author has an hindex of 22, co-authored 62 publications receiving 2646 citations. Previous affiliations of Thomas H. Brannagan include Columbia University Medical Center.
Papers
More filters
Journal ArticleDOI
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
David Adams,Alejandra González-Duarte,William O'Riordan,Chih-Chao Yang,Mitsuharu Ueda,Arnt V. Kristen,Ivailo Tournev,Hartmut Schmidt,Teresa Coelho,John L. Berk,Kon Ping Lin,Giuseppe Vita,Shahram Attarian,Violaine Planté-Bordeneuve,Michelle M. Mezei,Josep M. Campistol,Juan Buades,Thomas H. Brannagan,Byoung Joon Kim,Jeeyoung Oh,Yesim Parman,Yoshiki Sekijima,Philip N. Hawkins,Scott D. Solomon,Michael Polydefkis,Peter J. Dyck,Pritesh Gandhi,Sunita Goyal,Jihong Chen,Andrew Strahs,Saraswathy V. Nochur,Marianne T. Sweetser,Pushkal Garg,Pushkal Garg,Akshay Vaishnaw,Akshay Vaishnaw,Jared Gollob,Ole B. Suhr +37 more
TL;DR: Patisiran improved multiple clinical manifestations of hereditary transthyretin amyloidosis with polyneuropathy and showed an effect on gait speed and modified BMI.
Journal ArticleDOI
Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis
Scott D. Solomon,David Adams,Arnt V. Kristen,Martha Grogan,Alejandra González-Duarte,Mathew S. Maurer,Giampaolo Merlini,Thibaud Damy,Michel Slama,Thomas H. Brannagan,Angela Dispenzieri,John L. Berk,Amil M. Shah,Pushkal Garg,Akshay Vaishnaw,Verena Karsten,Jihong Chen,Jared Gollob,John Vest,Ole B. Suhr +19 more
TL;DR: The APOLLO study assessed the effect of hereditary transthyretin-mediated (hATTR) amyloidosis on cardiomyopathy or polyneuropathy as mentioned in this paper.
Journal ArticleDOI
Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial.
David M. Simpson,Justin C. McArthur,Richard K. Olney,David B. Clifford,Yuen T. So,David M. Ross,B. J. Baird,P. Barrett,Anne E. Hammer,Richard S. Baker,Russell Bartt,S. Becker,Joseph R. Berger,Thomas H. Brannagan,Bruce A. Cohen,C. Dorko,Ronald J. Ellis,D. M. Feinberg,K. Goodkin,Colin D. Hall,Princy Kumar,Camillo Marra,Richard B. Pollard,Giovanni Schifitto,Alex Tselis,K. Vollmer +25 more
TL;DR: Lamotrigine was well-tolerated and effective for HIV-associated neuropathic pain in patients receiving neurotoxic antiretroviral therapy, and patient and clinician ratings of global impression of change in pain were similar.
Journal ArticleDOI
Peripheral neuropathy in patients with inflammatory bowel disease.
Francisco de Assis Aquino Gondim,Thomas H. Brannagan,Howard W. Sander,Russell L. Chin,Norman Latov +4 more
TL;DR: A retrospective review of patients with PN and either Crohn's disease or ulcerative colitis found that demyelinating forms may occur at any time, but early in the IBD course, pure sensory neuropathy is more common.
Journal ArticleDOI
Comparison of sensitivity and specificity among 15 criteria for chronic inflammatory demyelinating polyneuropathy
Ari Breiner,Thomas H. Brannagan +1 more
TL;DR: In the patient population, the EFNS and Neuropathy Association criteria stand out due to high sensitivity and specificity, and, among the 3 most sensitive criteria, theEFNS and Neuroscience Association criteria were most specific.